DSpace About DSpace Software 日本語

01 奈良県立医科大学 >
011 医学部 >
0112 紀要 >
01121 Journal of Nara Medical Association >
Vol.46 No.2 >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10564/809

Authors: Kishimoto, Toshifumi
Ueda, Atsushi
Noriyama, Yoshinobu
Nagai, Toshiya
Hirayama, Tomohide
Kirita, Ikuhiro
Hata, Kazuya
Ikawa, Genro
Keywords: electroconvulsive therapy
depressive disorder
Issue Date: 30-Apr-1995
Publisher: 奈良医学会
Citation: 奈良医学雑誌 Vol.46 No.2 p.148-152
Abstract: We surveyed the clinical electroconvulsive therapy (ECT) treatment expe- riences between 1987 and 1992 at Nara Medical University Hospital. ECT is restrictedly applied to severely ill patients who have no response to other somatic therapies. For 5 years, 43 cases were treated with ECT, of which 27 suffered from depressive disorders, 3 from schizophrenia, 3 from somatoform disorders, and 10 from anxiety disorders. ECT was selected by psychiatrists for severe depressive states after failure of psychopharmacological therapy. A favorable therapeutic response to ECT was observed in 69% of patients with major depression, in 2 of 3 patients with schizophrenia, and in 70% of patients with anxiety disorders. In 2 of 3 patients with somatoform disorders, amelioration of the depressive or anxiety syndrome was not observed. Side effects of ECT were reversible memory distur- bance (16%), retrograde partial amnesia (12%), and reversible confusional state (5%). These results suggest that ECT is highly effective in therapy resistant major depression, schizophrenia, and anxiety disorders. Therefore ECT still remains a necessary part of psychiatric therapy.
URI: http://hdl.handle.net/10564/809
ISSN: 04695550
Appears in Collections:Vol.46 No.2

Files in This Item:

File Description SizeFormat

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback